Rice Hall James & Associates’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Rice Hall James & Associates’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-36,210	Closed	-$201K	–	316
2016 Q3	$201K	Buy	36,210 +404	+1%	+$2.67K	0.01%	291
2016 Q2	$251K	Sell	35,806 -288	-0.8%	-$2.03K	0.01%	282
2016 Q1	$239K	Sell	36,094 -558	-2%	-$4.11K	0.01%	284
2015 Q4	$378K	Buy	36,652 +1,053	+3%	+$12.2K	0.02%	268
2015 Q3	$419K	Sell	35,599 -1,638	-4%	-$18.1K	0.03%	266
2015 Q2	$341K	Buy	+37,237	New	+$281K	0.02%	285

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Rice Hall James & Associates's JNP Position: Q4 2016 in Review

Rice Hall James & Associates sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2016, closing a stake of 36,210 shares — an estimated $201K sold.

Rice Hall James & Associates first reported a position in JNP in Q2 2015 and held it in 6 quarters. The position peaked at $419K in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

Rice Hall James & Associates reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Rice Hall James & Associates sold 36,210 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $201K.
Rice Hall James & Associates first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
Rice Hall James & Associates's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $419K in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on Rice Hall James & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.